GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Genome & Co (XKRX:314130) » Definitions » Accounts Payable

Genome (XKRX:314130) Accounts Payable : ₩481 Mil (As of Dec. 2024)


View and export this data going back to 2018. Start your Free Trial

What is Genome Accounts Payable?

Genome's Accounts Payable for the quarter that ended in Dec. 2024 was ₩481 Mil.

Genome's quarterly Accounts Payable declined from Jun. 2024 (₩1,004 Mil) to Sep. 2024 (₩542 Mil) and declined from Sep. 2024 (₩542 Mil) to Dec. 2024 (₩481 Mil).

Genome's annual Accounts Payable increased from Dec. 2022 (₩205 Mil) to Dec. 2023 (₩340 Mil) and increased from Dec. 2023 (₩340 Mil) to Dec. 2024 (₩481 Mil).


Genome Accounts Payable Historical Data

The historical data trend for Genome's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genome Accounts Payable Chart

Genome Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Accounts Payable
Get a 7-Day Free Trial - 321.40 205.18 340.20 481.20

Genome Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Accounts Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 340.20 772.26 1,003.54 541.78 481.20

Genome Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.


Genome Accounts Payable Related Terms

Thank you for viewing the detailed overview of Genome's Accounts Payable provided by GuruFocus.com. Please click on the following links to see related term pages.


Genome Business Description

Traded in Other Exchanges
N/A
Address
Innovalley A-801, Pangyo-ro 253, Bundang-gu, Gyeonggi-do, Seongnam-si, KOR, 13486
Genome & Co is a Korean company engaged in researching and developing dietary supplements, cosmeceuticals, and new drugs. Its products pipeline includes immunooncology therapeutic supplement for treatment of immuno-oncology, lung cancer, colorectal cancer, stomach cancer, breast cancer, pancreatic cancer; dietary supplements for treating obesity and diabetes; cosmetics used for acne and atopic dermatitis; and also produces In Virto fertilization medicine.

Genome Headlines

No Headlines